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1. Introduction 
Numerous studies insist upon the importance of 
cell surface carbohydrates for a variety of cell recogni- 
tion phenomena. In particular, glycoconjugates have 
been shown to be involved in the binding by cell mem- 
brane receptors of certain bacterial toxins, lectins and 
hormones [l-4]. 
For insulin, carbohydrates were implicated in spe- 
cific hormone binding [5-l 11. For normal hepatic 
cells, terminal galactose residues and accessible man- 
nose groups were involved in high affinity insulin 
binding [6]. Our studies have analysed the insulin 
binding characteristics of transformed hepatic cells 
(Zajdela rat ascites hepatoma cells). These results 
showed that the number of specific insulin receptors 
was decreased as compared to normal hepatocytes 
but that their characteristics were not modified (pH 
and temperature dependance, curvilinear plots 
obtained by Scatchard analysis, dissociation of bound 
insulin increased by insulin). However, terminal 
/_?-galactose groups were not implicated in the binding 
process [7]. 
To explain this difference between normal and 
transformed hepatic cells and to study the nature of 
carbohydrate residues involved in insulin binding to 
hepatoma cells, the effect of different glycosidases 
and lectins was investigated. 
Our results indicate the importance of sialogalacto- 
glycopeptides for insulin binding. They lead to the 
Abbreviations: BSA, bovine serum albumin; con A, concana- 
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glucosamine; KRP, Krebs-Ringer phosphate; Man, cr-mannose; 
NeuNAc, Nacetyl-neuraminic acid; PNA, peanut agglutinin; 
RCA, Ricinus communis agglutinin 1; SBA, soyabean agglu- 
tinin; UeAF, Alex europeus agglutinin; WGA, wheat germ 
agglutinin 
hypothesis of a model concerning the role of glyco- 
conjugates in the insulin binding process, which is 
discussed here. 
Preliminary reports of these findings have been 
published [9]_ 
2. Materials and methods 
2.1. Preparation of cells and insulin binding studies 
Zajdela ascites hepatoma cells (strain D) were 
transplanted and prepared, as in [7], in Krebs-Ringer 
phosphate buffer (pH 7.6) 1.5% BSA. Insulin bind- 
ing experiments using [“‘I]insulin (SO-100 pCi/cg 
Radiochemical Centre, Amersham) and a native 
insulin (Novo Labs, Pork Insulin MC) were performed 
at 4°C as in [7] except that at the end of the incuba- 
tion period the cells were washed once. All experi- 
ments were repeated at least 3 times. 
2.2. Enzymic digestions 
Two neuraminidases from Clostridium perfringens 
(l-5 mu/lo6 cells, Worthington NEUA 18 U/mg) 
and from Vibrio cholerae (OS-5 U/lo6 cells, Institut 
Behring ORKD 500 U/ml), /3-galactosidase (O-500 
mu/IO” cells, Worthington BGC 500 U/mg) and a-L- 
fucosidase from beef kidney (I -5 mu/lo6 cells 
Boehringer Mannheim 1 U/mg) were employed. Diges- 
tions were for 30 min at 37’C as in [7]. 
2.3. Effect of lectins 
Lectins used were: Ricinus communis agglutinln I 
(type 120 from castor beans), peanut agglutinin 
(from Arachis hypogea), soyabean agglutinin (from 
soyabean Glycine max), Vlex europeus agglutinin 
(from gorse seeds) and wheat germ agglutinin (from 
wheat germ Triticum uulgare), from Reactifs IBF 
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(Pharmindustrie), concanavalin A (from jack bean 
Canavalia ensiformis) from Worthington Biochem. 
The saccharide binding specificities of the different 
lectins were [12-141: for RCA, and PNA, terminal 
fl-galactose (Gal); for SBA, terminal galactose and 
N-acetyl-galactosamine; for UeAf, terminal a-Fuc; 
for WGA, terminal or internal N-acetyl-glucosamine 
and N-acetyl-neuraminic acid; for con A, terminal or 
internal cr-mannose and o-glucose. 
Cells (1-2 X 106) were incubated with various 
concentrations of lectins, either at 22°C (UeAF, 
con A) or at 4°C (PNA, SBA, RCA, WGA), in order 
to ensure good conditions for binding 1151, for 1 h in 
0.5 ml KRP buffer 1.5% BSA, (pH 7.6). Insulin bind- 
ing experiments were then done at 4’C as above. 
Control tubes for the specificity of lectin binding 
were assayed with lectin specific sugars, i.e., lactose 
(Reactifs IBF, Pharmindustrie) for RCA, PNA and 
SBA, fucose (Sigma Chem.) for UeAF and Glc NAc 
(Sigma) for WGA, lectins having been preincubated 
for 20 min at 22’C in the presence of 0.05 M of the 
respective sugar prior to addition of the cells. The 
effect of lectins was also tested in some cases after 
neuraminidase treatment of hepatoma cells. 
In some cases, cell agglutination was observed 
when high lectin concentrations were added to the 
cells. However this agglutination did not impede 
insulin binding since maximal agglutination could 
occur without a decrease in insulin binding. In par- 
ticular for certain lectin concentrations, cell aggluti- 
nation was observed when RCA, PNA, SBA or WGA 
were incubated with intact or desialylated cells even 
when the insulin binding was not decreased: the effect 
of RCA, PNA or SBA on intact cells, the effect of 
WGA plus Glc NAc on intact cells. 
We also verified that the effect of lectins was spe- 
cific and not toxic by showing that addition of spe- 
cific sugars impeded the inhibitory effect of lectins 
upon insulin binding. If a non-specific sugar at the 
same molar&y was added to the preparation, the lectin 
effect was the same as when in its absence even though 
the osmolarity was increased. 
3. Results and discussion 
3 .I. Effect of sialidase, /_-galactosidase and gahctose 
specific lectins 
Two different neuraminidases (from Clostridium 
perfingens and Vibrio cholerae) were tested. In each 
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Fig.1. Effect of Pgalactosidase digestion upon the specific 
insulin binding by Zajdela hepatoma cells. Cells were digested 
with various concentrations of: (0) pgalactosidase alone; (m) 
pgalactosidase plus neuraminidase from CIostridium per- 
fringens (5 mu/lo6 cells); (*) pgalactosidase plus neur- 
aminidase from Vibrio cholerue (0.5 U/lo6 cells); under the 
conditions indicated in the text. 
case insulin binding was not modified after enzymic 
treatment of Zajdela hepatoma cells even with enzyme 
concentrations hydrolyzing 1.5 pg sialic acid/lo6 
cells. 
Similarly, when /3-galactosidase was employed, 
insulin binding was not modified. However, when 
hepatoma cells were digested with sialidase plus 
P-galactosidase, an inhibition of specific insulin 
binding to cells was observed (fig-l). This inhibition 
increased with increasing concentrations of fl-galactosid- 
ase and was 30% of the total binding when employ- 
ing 0.4 U enzyme/lo’ cells. Scatchard analysis showed 
that the inhibition only affected the number of high 
affinity sites (table l), the dissociation constants 
remaining unmodified. 
Concordant results were observed when the effect 
of 3 galactose-specific lectins (RCA, PNA, SBA) was 
studied. When intact Zajdela hepatoma cells were 
used no modification in insulin binding was observed. 
On the contrary, when the cells were pretreated with 
sialidase, the addition of the lectins SBA, PNA or 
RCA resulted in an inhibition of 30-35% of insulin 
binding (fig.2). This effect could be accorded to spe- 
cific lectin binding to galactose and toxic alterations 
could be excluded as it was reversed when lectins 
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Table 1 
Effect of various glycosidases and lectins on the number of high and low affinity 
insulin binding sites 
Agent Variation in the number of: 
High affinity Low affinity 
sites (%) sites (%) 
Control 0 0 
pGa.lactosidase (0.2 U/10” cells) 0 0 
Neuraminidase (5 mU/l O6 cells) 0 0 
p-Galactosidase (0.2 U/l O6 cells) 
+ neuraminidase (5 mu/lo6 cells) 
-20 0 
o-Fucosidase (5 mU/106 cells) 0 0 
ulcx europals (20 pg/l O6 cells) -20 -20 
Concanavalin A (20 rig/l O6 cells) -30 -5 
Insulin binding characteristics were determined from Scatchard analysis as in [7], 
experiments being repeated >3 times. For control cells the number of high affinity 
binding sites was 46O/cell and for low affinity sites 11 OOO/ceU 
a 
PEANUT AGGLUTININ ( pg/106cells) 
. . 
. . . . . l . . . 
--.- 
P 
b 
SOYA BEAN AGGLUTlNlN ( lJg/lO%ells ) 
August 1980 
were preincubated with lactose (fig.2). 
Thus our results using enzymes and lectins indicate 
the presence of fl-galactose groups implicated in high 
affinity insulin binding to hepatoma cells. However 
these galactose residues are not directly accessible to 
binding being masked by sialic acid moieties probably 
linked to galactoses and the presence of which does 
not modify insulin binding characteristics. 
The non-involvement of siahc acid in insulin bind- 
ing was proposed for normal cells [6,16] and galacto- 
C 
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Fig.2. Effect of galactose specific lectins PNS, SBA and RCA 
on insulin binding to Zajdela hepatoma cells. (a) Effect of 
PNA, (b) effect of SBA, (c) effect of RCA, on: (0) intact cells; 
(e) desialylated cells; (A) desialylated cells + lactose. For 
experimental details see text. 
27 
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glycoconjugates playing a role in high affinity insulin 
binding were directly revealed for normal hepatic 
plasma membranes [6]. 
For hepatoma cells, the intervention of sialic acid 
in this process could be related to an increased sialic 
acid content found on the surface of different hepa- 
toma strains [ 17- 193, galactose residues being acces- 
sible only after neuraminidase treatment. On the con- 
trary, for normal hepatic cells, receptors for RCA 
[20] and for insulin [6], possessing terminal galactose 
moieties, were directly revealed. 
3.2. Effect of or-fucosidase and Ulex europeus lectin 
When hepatoma cells were digested with a-fuco- 
sidase, no modification in insulin binding was noted. 
However when the effect of the lectin UeAF, specific 
10 2-O 3-O 4b 
ULEX EUROPEUS ( ~g/lO%ells~) 
$ II& 
WHEAT GERM AGGLUTININ ( ~g11O%ells) 
Fig.3. Effect of UeAF and WGA on specific insulin binding 
to Zajdela hepatoma cells. (a) Effect of UeAF upon: (0) 
intact cells; (=) intact cells + fucose; (A) desialylated cells. 
(b) Effect of WGA upon: (0) intact cells; (=) intact cells + Glc 
NAc; (A) desialylated cells. 
for fucose, was investigated a 20% inhibition of 
insulin binding was observed with 10 ng lectin/106 
cells (fig.3a) and this effect was specific for fucose. 
When desialylated cells were used, the same results 
were observed as for intact cells. Scatchard analysis 
of this effect showed a 20% reduction in the number 
of high and low affmity insulin binding sites (table 1) 
without modification in their affinity. 
Thus, for Zajdela hepatoma cells, although the 
hydrolysis of fucose residues by fucosidase did not 
modify insulin binding, the binding of UeAF to fucose 
resulted in an inhibition. Studies with normal hepatic 
cells concerning the effect of fucosidase and UeAF 
did not reveal any modification in either case ([6] 
and in press). Thus it seems likely that, for hepatoma 
cells, fucose residues are linked or close to sialogalacto- 
glycoconjugates involved in insulin binding. These 
fucose groups are not implicated in the insulin recog- 
nition process. However, when UZex lectln is attached 
to fucose moieties, steric occupation of insulin recep- 
tors may partially impede hormone binding. 
The presence of excess fucose residues in glyco- 
conjugates of Zajdela hepatoma cells involved in 
insulin binding could be related to an increased cell 
surface fucose content as found in surface glycopro- 
teins for hepatoma cells [17,18,21]. 
3.3. WGA 
The effect of WGA on insulin binding to intact 
hepatoma cells was investigated. A biphasic effect 
was noted: a slight enhancement with low concen- 
trations of the lectin and a marked inhibition with 
higher concentrations (fig.3b), insulin binding being 
decreased by 75% with WGA at 40 ng/106 cells. If 
WGA was preincubated with its specific sugar, Glc 
NAc, no inhibition could be noted. To the contrary, 
insulin binding was slightly enhanced (fig.3b). These 
results suggest hat the increased insulin binding, 
observed when using low lectin concentrations and 
which is not reversed by Glc NAc, could be due to 
non-specific lectin effects. 
The inhibition of insulin binding by desialylated 
cells, after WGA action, could be explained by the 
binding of the lectin to Glc NAc residues, even when 
in the non-terminal non-reducing position [ 121. This 
effect indicated the importance of Glc NAc moieties 
in the insulin receptor. The differences noted between 
desialylated and intact hepatoma cells could be 
accounted to the binding of WGA to sialic acid resi- 
dues [12,13,22]. Since WGA posseses 4 carbohydrate 
28 
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binding regions, multivalent interactions with surface 
sialoglycoconjugates [161 could result in partial steric 
occupation of insulin binding sites. 
The effect of con A was also studied as in [7]. A 
30% inhibition of insulin binding was noted when 
using moderate con A concentrations: this inhibition 
affected the number of high affinity sites (table 1). 
The effect of con A and WGA on insulin binding 
was described for normal cells [5,6,11,23] and led to 
the conclusion that common insulin and con A 
binding sites exist and that the insulin receptor has a 
glycosidic structure. 
Thus our studies with glycosidases and lectins 
indicate that galactose residues are implicated in 
insulin binding to high affinity sites: mannose and 
N-acetyl-glucosamine molecules probably form the 
core of this glycoconjugate. Furthermore, for Zajdela 
hepatoma cells, sialic acid and fucose groups are either 
linked or close to this (or these) glycopeptide(s). 
This carbohydrate composition has been described 
for certain types of N-linked oligosaccharide side- 
chains usually possessing a core sequence containing 
Man and Glc NAc, branched chains linked via the 
sequence Gal-Glc NAc to internal Man residues, 
NeuNAc groups in non-reducing terminal positions 
and sometimes Fuc linked to Gal or Glc NAc [24], 
and in particular for con A receptor fractions isolated 
from rat hepatomas [25]. These structures were found 
on the surface of normal and transformed cells 
[26,27], the latter possessing an increased number of 
terminal sialic acid and fucose residues [28]. 
It is difficult to relate this low specificity of the 
glycosidic structure to highly specific insulin. binding. 
Thus it is tempting to speculate that this (or these) 
glycopeptide(s) is (are) not directly involved in initial 
insulin binding to an acceptor site, but that the inter- 
action of the carbohydrate moiety with the insulin- 
acceptor complex transforms the low affinity linkage 
to a high affinity one. This glycosidic struture may be 
a part of, or functionally linked to, the receptor mole- 
cule and thus could modulate insulin specific action. 
This hypothesis for the functional heterogeneity 
of insulin receptors was studied [29]. It was postulated 
that initially insulin binds to a low affinity cell sur- 
face receptor and that secondly some parts of this 
complex are converted to a high affinity form. 
Other works demonstrate the importance of a cell 
membrane glycoprotein in the insulin binding process 
[ 10,30]. Thus the interaction of the homogeneous 
low affinity insulin binding species with a membrane 
glycoprotein resulted in the appearance of a high 
affinity binding plateau, suggesting that this glycopro- 
tein may represent an effector, or a non-recognition 
moiety, of the receptor oligomer, that confers special 
binding properties to the receptor complex [lo]. 
Studies using normal liver plasma membranes 
indicate that two membrane galactoglycoproteins are 
involved in the specific insulin recognition process 
t&91. 
In [ 1 l] con A-like binding sites were speculated to 
exist on the cell membrane and are a part of, or func- 
tionally linked to, the insulin receptor. This carbo- 
hydrate moiety present on the membrane might affect 
the binding of insulin and control its action. 
Thus the following attractive hypothesis could be 
put forward: in normal cells a N-glycopeptidic struc- 
ture containing Man, Glc NAc and Gal is a constituant 
of a glycoprotein linked to or close to the acceptor 
site for insulin. The hormone binds initially to the 
acceptor molecule with a low affinity and secondly 
this association with the glycopeptidic moiety gives 
rise to a high affinity complex which can modulate the 
hormone action. This glycoproteic fraction may form 
a non-recognition part of the receptor oligomer or 
may contain effector molecule(s) with which the 
insulin receptor may interact within the plane of the 
membrane, as postulated by the mobile receptor par- 
adigm [3 11. 
An alternative explanation, although less probable, 
could be considered in regard to the theory of negative 
cooperativity [3 1,321: the glycosidic fraction could 
be involved in site-site interactions, its position of 
fmation to the insulin receptor being partially masked 
in the high affinity form of the molecule. 
For hepatoma cells, this glycopeptidic moiety 
possesses added sialic acid and fucose residues. This 
increased glycosylation for transformed hepatocytes 
does not modify their insulin binding characteristics 
as demonstrated both previously and here. The dif- 
ferences observed between normal and transformed 
cells in the effect of lectins and enzymes could be 
explained by modification in the surface receptor 
environment with an increased sialic acid and fucose 
content. 
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